Brouky Score · 2026

Top VC Firms in Switzerland

The 25 highest-scoring venture funds headquartered in Switzerland, ranked from 101 eligible firms on a 110-point composite of portfolio outcomes, deal volume, risk adjustment and cheque-size fit.

71
Median score / 110
across eligible firms
101
Eligible firms
5+ tracked investments
3,761
Tracked investments
in this market
25
Firms ranked
highest scoring
Sort by
1

Swisscom Ventures

Corporate VCSeries C+Switzerland
Software & Developer ToolsHealthcare & Life SciencesIndustry & HardwareEnergy, Environment & MobilityFinance & BlockchainArtificial Intelligence & Data+3 more
aicybersecuritythreat-detectionfintechanalyticsmachine-learning+3 more

Swisscom Ventures invests primarily in Swiss and nearby European technology startups focusing on software, robotics, and AI across seed to later stages. They target B2B business models supporting digital transformation and innovation.

99/ 110Grade A

Investments

68

Portfolio Size

—

Exit Rate

—

Alive

—

Portfolio Status

Not enough tracked outcomes yet

Portfolio Liveness

No alive portfolio to assess

Score Breakdown

Size Fit
15 / 15
Venture Signals
14 / 25
Deal Volume
30 / 30
Portfolio Outcomes
40 / 40
2

Endeavour Vision

Series C+Switzerland
Healthcare & Life SciencesSoftware & Developer ToolsConsumer, Lifestyle & Services
digital-healthhealthcarechronic-paingynecologymedical-devicesendovascular+3 more

Focuses on early-stage companies in the healthcare and life sciences sector, primarily in Europe. They look for innovative solutions that improve patient outcomes and healthcare delivery.

99/ 110Grade A

Investments

23

Portfolio Size

—

Exit Rate

—

Alive

—

Portfolio Status

Not enough tracked outcomes yet

Portfolio Liveness

No alive portfolio to assess

Score Breakdown

Size Fit
15 / 15
Venture Signals
14 / 25
Deal Volume
30 / 30
Portfolio Outcomes
40 / 40
3

Schroder Adveq

Series C+Switzerland
Healthcare & Life SciencesIndustry & Hardware
biotechdrug-developmenthealthcarepharmaceutical-developmentprecision-mediciner-d+3 more

Schroder Adveq focuses on growth-stage investments primarily in Switzerland, targeting healthcare and biotechnology sectors. They invest across seed and series-c-plus stages, backing innovative companies with scalable B2B business models.

99/ 110Grade A

Investments

11

Portfolio Size

—

Exit Rate

—

Alive

—

Portfolio Status

Not enough tracked outcomes yet

Portfolio Liveness

No alive portfolio to assess

Score Breakdown

Size Fit
15 / 15
Venture Signals
14 / 25
Deal Volume
30 / 30
Portfolio Outcomes
40 / 40
4

ND Capital

Series C+Switzerland
Healthcare & Life SciencesIndustry & HardwareSoftware & Developer ToolsEnergy, Environment & MobilityFinance & BlockchainArtificial Intelligence & Data+3 more
drug-developmentbiotechnologyprecision-medicineinfectious-diseasesgenomicsrna-editing+3 more

+ND Capital is a venture capital firm founded in 2002 that invests in disruptive technologies across life, physical, and data sciences. It invests across the United States and Europe and across sectors, stages, and technologies.

97/ 110Grade A

Investments

32

Portfolio Size

—

Exit Rate

—

Alive

—

Portfolio Status

Not enough tracked outcomes yet

Portfolio Liveness

No alive portfolio to assess

Score Breakdown

Size Fit
15 / 15
Venture Signals
12 / 25
Deal Volume
30 / 30
Portfolio Outcomes
40 / 40
5

Helvetica Capital

Series C+Switzerland
Industry & HardwareSoftware & Developer ToolsHealthcare & Life SciencesEnergy, Environment & MobilityFinance & BlockchainCommerce & Marketing+3 more
manufacturingindustrialhardwarehealthcareconsumer-hardwareasset-management+3 more

Helvetica Capital is an independent, entrepreneurial investor focusing on companies in Switzerland and neighboring regions. They provide capital and advise both entrepreneurs and investors on financing and succession solutions.

97/ 110Grade A

Investments

27

Portfolio Size

—

Exit Rate

—

Alive

—

Portfolio Status

Not enough tracked outcomes yet

Portfolio Liveness

No alive portfolio to assess

Score Breakdown

Size Fit
15 / 15
Venture Signals
14 / 25
Deal Volume
30 / 30
Portfolio Outcomes
38 / 40
6

Pureos Bioventures

Series ASwitzerland
Healthcare & Life SciencesSoftware & Developer ToolsCommerce & Marketing
biotechr-ddrug-developmenttherapeuticsclinical-stagehealthcare+3 more

Pureos Bioventures is a venture capital based in Schwyz, Switzerland. The firm seeks to invest in the drug development sector.

97/ 110Grade A

Investments

17

Portfolio Size

—

Exit Rate

—

Alive

—

Portfolio Status

Not enough tracked outcomes yet

Portfolio Liveness

No alive portfolio to assess

Score Breakdown

Size Fit
15 / 15
Venture Signals
14 / 25
Deal Volume
28 / 30
Portfolio Outcomes
40 / 40
7

Pictet

Series BSwitzerland
Healthcare & Life SciencesSoftware & Developer ToolsEnergy, Environment & MobilityCommerce & MarketingIndustry & HardwareConsumer, Lifestyle & Services+3 more
aidrug-developmentrare-diseasesbiotechai-automationcarbon-fiber+3 more

Pictet is an investment group offering wealth management, asset management and related services. The firm does not engage in investment banking nor extend commercial loans.

96/ 110Grade A

Investments

20

Portfolio Size

—

Exit Rate

—

Alive

—

Portfolio Status

Not enough tracked outcomes yet

Portfolio Liveness

No alive portfolio to assess

Score Breakdown

Size Fit
15 / 15
Venture Signals
14 / 25
Deal Volume
30 / 30
Portfolio Outcomes
37 / 40
8

Swiss Post Ventures

Corporate VCSeries ASwitzerland
Software & Developer ToolsHealthcare & Life SciencesEnergy, Environment & MobilityIndustry & HardwareFinance & Blockchain+2 more
healthcareanalyticsautomationdataaiproject-management+3 more
95/ 110Grade A

Investments

31

Portfolio Size

—

Exit Rate

—

Alive

—

Portfolio Status

Not enough tracked outcomes yet

Portfolio Liveness

No alive portfolio to assess

Score Breakdown

Size Fit
15 / 15
Venture Signals
15 / 25
Deal Volume
30 / 30
Portfolio Outcomes
35 / 40
9

Climb Ventures

Series C+Switzerland
Software & Developer ToolsConsumer, Lifestyle & ServicesIndustry & Hardware
hr-techedtechcloud-computingdata-analyticsenterprise-softwaregraph-database+3 more

Focuses on Series C and later stage investments in Switzerland. Primarily invests in B2B companies within the Industry & Hardware sector.

94/ 110Grade A

Investments

14

Portfolio Size

—

Exit Rate

—

Alive

—

Portfolio Status

Not enough tracked outcomes yet

Portfolio Liveness

No alive portfolio to assess

Score Breakdown

Size Fit
15 / 15
Venture Signals
16 / 25
Deal Volume
23 / 30
Portfolio Outcomes
40 / 40
10

Energie 360°

Series ASwitzerland
Energy, Environment & MobilitySoftware & Developer Tools
clean-energyenergy-managementrenewable-energysustainabilityenergy-storageanalytics+3 more
94/ 110Grade A

Investments

11

Portfolio Size

—

Exit Rate

—

Alive

—

Portfolio Status

Not enough tracked outcomes yet

Portfolio Liveness

No alive portfolio to assess

Score Breakdown

Size Fit
15 / 15
Venture Signals
16 / 25
Deal Volume
23 / 30
Portfolio Outcomes
40 / 40
11

Decheng Capital

Series C+Switzerland
Healthcare & Life SciencesSoftware & Developer ToolsConsumer, Lifestyle & ServicesIndustry & HardwareFinance & Blockchain+2 more
r-dbiotechhealthcaredrug-developmentoncologypharmaceutical-development+3 more

Focuses on investments in the healthcare and life sciences sector. Primarily invests in companies located in Switzerland.

91/ 110Grade A-

Investments

39

Portfolio Size

—

Exit Rate

—

Alive

—

Portfolio Status

Not enough tracked outcomes yet

Portfolio Liveness

No alive portfolio to assess

Score Breakdown

Size Fit
15 / 15
Venture Signals
12 / 25
Deal Volume
30 / 30
Portfolio Outcomes
34 / 40
12

Syngenta Group Ventures

Corporate VCSeries ASwitzerland
Industry & HardwareSoftware & Developer ToolsArtificial Intelligence & DataCommerce & MarketingEnergy, Environment & Mobility+2 more
agritechanalyticsdataaialternative-lendingfintech+3 more
91/ 110Grade A-

Investments

11

Portfolio Size

—

Exit Rate

—

Alive

—

Portfolio Status

Not enough tracked outcomes yet

Portfolio Liveness

No alive portfolio to assess

Score Breakdown

Size Fit
15 / 15
Venture Signals
16 / 25
Deal Volume
20 / 30
Portfolio Outcomes
40 / 40
13

BVF Partners

Series C+Switzerland
Healthcare & Life SciencesIndustry & Hardware
drug-developmentbiotechproteomicssmall-moleculetarget-identificationhealthcare+3 more
91/ 110Grade A-

Investments

10

Portfolio Size

—

Exit Rate

—

Alive

—

Portfolio Status

Not enough tracked outcomes yet

Portfolio Liveness

No alive portfolio to assess

Score Breakdown

Size Fit
15 / 15
Venture Signals
14 / 25
Deal Volume
30 / 30
Portfolio Outcomes
32 / 40
14

BioMedPartners

Series ASwitzerland
Healthcare & Life SciencesSoftware & Developer ToolsConsumer, Lifestyle & ServicesIndustry & Hardware+1 more
drug-developmentoncologyhealthcareantibody-drug-conjugatesbiologicspharmaceutical-development+3 more

BioMedPartners invests in innovative early-stage healthcare and life science companies. They focus on companies developing novel therapeutics and diagnostics.

89/ 110Grade A-

Investments

24

Portfolio Size

—

Exit Rate

—

Alive

—

Portfolio Status

Not enough tracked outcomes yet

Portfolio Liveness

No alive portfolio to assess

Score Breakdown

Size Fit
15 / 15
Venture Signals
14 / 25
Deal Volume
20 / 30
Portfolio Outcomes
40 / 40
15

Ace and Company

Series ASwitzerland
Software & Developer ToolsConsumer, Lifestyle & ServicesIndustry & HardwareArtificial Intelligence & DataCommerce & MarketingEnergy, Environment & Mobility+3 more
cybersecuritythreat-detectionenterpriseaianalyticsdata+3 more

ACE & Company is a private equity and venture capital group investing in early to late-stage technology startups through its ACE Swiss Tech Outliers fund and in lower mid-market buyouts and secondaries in private markets.

89/ 110Grade A-

Investments

19

Portfolio Size

—

Exit Rate

—

Alive

—

Portfolio Status

Not enough tracked outcomes yet

Portfolio Liveness

No alive portfolio to assess

Score Breakdown

Size Fit
15 / 15
Venture Signals
15 / 25
Deal Volume
26 / 30
Portfolio Outcomes
33 / 40
16

Syngenta Ventures

Series C+Switzerland
Industry & HardwareEnergy, Environment & MobilityArtificial Intelligence & DataHealthcare & Life SciencesFinance & BlockchainCommerce & Marketing+3 more
agritechcomputer-visionprecision-agriculturesustainabilityfresh-producesupply-chain+3 more

Syngenta Ventures invests in innovative Agtech and sustainable agriculture startups globally, focusing on scalable solutions that enhance crop protection, digital farming, and biotechnology to improve food security and environmental impact.

87/ 110Grade A-

Investments

31

Portfolio Size

—

Exit Rate

—

Alive

—

Portfolio Status

Not enough tracked outcomes yet

Portfolio Liveness

No alive portfolio to assess

Score Breakdown

Size Fit
15 / 15
Venture Signals
13 / 25
Deal Volume
30 / 30
Portfolio Outcomes
29 / 40
17

Polytech Ventures

Series ASwitzerland
Healthcare & Life SciencesConsumer, Lifestyle & ServicesFinance & BlockchainSoftware & Developer ToolsIndustry & Hardware+2 more
machine-learningbiotechhealthcaremedical-devicemedical-devicesmedtech+3 more

Polytech Ventures invests in early-stage companies, primarily in Switzerland. They focus on finance and blockchain, as well as consumer-oriented businesses.

86/ 110Grade A-

Investments

32

Portfolio Size

—

Exit Rate

—

Alive

—

Portfolio Status

Not enough tracked outcomes yet

Portfolio Liveness

No alive portfolio to assess

Score Breakdown

Size Fit
15 / 15
Venture Signals
11 / 25
Deal Volume
25 / 30
Portfolio Outcomes
35 / 40
18

EquityPitcher

Series ASwitzerland
Software & Developer ToolsIndustry & HardwareFinance & BlockchainConsumer, Lifestyle & ServicesHealthcare & Life SciencesEnergy, Environment & Mobility+3 more
aiautomationsaasenterprise-softwarecomplianceapi+3 more

We are a Venture Capital firm. We back entrepreneurs across industries, markets and stages.

86/ 110Grade A-

Investments

31

Portfolio Size

—

Exit Rate

—

Alive

—

Portfolio Status

Not enough tracked outcomes yet

Portfolio Liveness

No alive portfolio to assess

Score Breakdown

Size Fit
15 / 15
Venture Signals
14 / 25
Deal Volume
30 / 30
Portfolio Outcomes
27 / 40
19

BlueOcean Ventures

Series ASwitzerland
Healthcare & Life SciencesIndustry & HardwareSoftware & Developer ToolsCommerce & Marketing+1 more
hardwarer-dmedical-devicemedtechmedical-technologyiot+3 more

BlueOcean Ventures invests in early stage medical device and life science companies primarily in Switzerland and Europe. They focus on highly promising early stage Medical Device and Diagnostics companies, with secondary focus on startups in Life Sciences, digital health, and nanotechnologies.

86/ 110Grade A-

Investments

18

Portfolio Size

—

Exit Rate

—

Alive

—

Portfolio Status

Not enough tracked outcomes yet

Portfolio Liveness

No alive portfolio to assess

Score Breakdown

Size Fit
15 / 15
Venture Signals
14 / 25
Deal Volume
30 / 30
Portfolio Outcomes
27 / 40
20

Revival Healthcare Capital

Series C+Switzerland
Healthcare & Life SciencesSoftware & Developer Tools
healthcaremedical-devicemedtechsurgical-technologyminimally-invasivehardware+3 more

Revival Healthcare Capital invests in the medical device and diagnostics sectors, focusing on MedTech companies. The firm invests through flexible capital and partners with portfolio companies across various stages using their experience as investors and operators in healthcare.

86/ 110Grade A-

Investments

14

Portfolio Size

—

Exit Rate

—

Alive

—

Portfolio Status

Not enough tracked outcomes yet

Portfolio Liveness

No alive portfolio to assess

Score Breakdown

Size Fit
15 / 15
Venture Signals
14 / 25
Deal Volume
30 / 30
Portfolio Outcomes
27 / 40
21

Redalpine

Series ASwitzerland
Software & Developer ToolsHealthcare & Life SciencesFinance & BlockchainIndustry & HardwareConsumer, Lifestyle & ServicesCommerce & Marketing+3 more
aimobile-appsustainabilitymachine-learningworkflow-automationgenerative-ai+3 more

Redalpine is an early-stage venture capital firm focusing on European startups with disruptive technologies and scalable business models. They invest across various sectors, including digital health, e-commerce, and software.

85/ 110Grade A-

Investments

209

Portfolio Size

—

Exit Rate

—

Alive

—

Portfolio Status

Not enough tracked outcomes yet

Portfolio Liveness

No alive portfolio to assess

Score Breakdown

Size Fit
15 / 15
Venture Signals
0 / 25
Deal Volume
30 / 30
Portfolio Outcomes
40 / 40
22

Lakestar

Series ASwitzerland
Software & Developer ToolsIndustry & HardwareConsumer, Lifestyle & ServicesFinance & BlockchainHealthcare & Life SciencesCommerce & Marketing+3 more
aiautomationconsumerfinancial-servicesenterprisefintech+3 more

Lakestar is an investment firm founded in 2012 that invests across stages and geographies, focusing on European technology companies in critical technologies to support Europe's sovereignty and prosperity.

85/ 110Grade A-

Investments

183

Portfolio Size

—

Exit Rate

—

Alive

—

Portfolio Status

Not enough tracked outcomes yet

Portfolio Liveness

No alive portfolio to assess

Score Breakdown

Size Fit
15 / 15
Venture Signals
0 / 25
Deal Volume
30 / 30
Portfolio Outcomes
40 / 40
23

HBM Healthcare Investments

Series C+Switzerland
Healthcare & Life SciencesSoftware & Developer ToolsConsumer, Lifestyle & ServicesEnergy, Environment & MobilityCommerce & MarketingIndustry & Hardware+3 more
drug-developmentbiotechhealthcarer-doncologyclinical-stage+3 more

HBM Healthcare Investments focuses on investments in the healthcare sector. They invest across various stages, with a significant focus on companies developing innovative therapeutics and technologies.

85/ 110Grade A-

Investments

180

Portfolio Size

—

Exit Rate

—

Alive

—

Portfolio Status

Not enough tracked outcomes yet

Portfolio Liveness

No alive portfolio to assess

Score Breakdown

Size Fit
15 / 15
Venture Signals
0 / 25
Deal Volume
30 / 30
Portfolio Outcomes
40 / 40
24

Backbone Ventures

Pre-SeedSwitzerland
Software & Developer ToolsHealthcare & Life SciencesConsumer, Lifestyle & ServicesFinance & BlockchainIndustry & HardwareEnergy, Environment & Mobility+3 more
consumerhealthcareconsumer-techsustainabilitydigital-healthd2c+3 more

BackBone Ventures is a Swiss venture capital firm that invests in early-stage technology companies across Europe. They focus on pre-seed and seed rounds, backing ambitious founders with disruptive ideas and scalable business models. They look for companies with strong teams, innovative technologies, and large addressable markets.

85/ 110Grade A-

Investments

55

Portfolio Size

—

Exit Rate

—

Alive

—

Portfolio Status

Not enough tracked outcomes yet

Portfolio Liveness

No alive portfolio to assess

Score Breakdown

Size Fit
15 / 15
Venture Signals
9 / 25
Deal Volume
30 / 30
Portfolio Outcomes
31 / 40
25

Venture Kick

Pre-SeedSwitzerland
Industry & HardwareHealthcare & Life SciencesSoftware & Developer ToolsEnergy, Environment & MobilityConsumer, Lifestyle & ServicesArtificial Intelligence & Data+3 more
analyticsdatahardwarecybersecurityaibiotech+3 more

Venture Kick is a Swiss early-stage investor focused on supporting pre-seed and seed startups primarily in Switzerland, fostering innovation across various sectors through funding and mentoring.

84/ 110Grade B+

Investments

96

Portfolio Size

—

Exit Rate

—

Alive

—

Portfolio Status

Not enough tracked outcomes yet

Portfolio Liveness

No alive portfolio to assess

Score Breakdown

Size Fit
6 / 15
Venture Signals
8 / 25
Deal Volume
30 / 30
Portfolio Outcomes
40 / 40

Methodology

What the score measures, who is eligible, and what it deliberately excludes.

How is the Brouky score for Switzerland calculated?
Each firm is scored out of 110 points across four measured components: portfolio outcomes (40), deal volume (30), risk adjustment (25) and cheque-size fit (15). The score is computed from tracked investments and portfolio company status. It is not editorial and firms cannot influence it.
Which firms are eligible for the Switzerland ranking?
Venture and corporate venture funds headquartered in Switzerland with at least 5 tracked investments. 101 firms qualify; the top 25 are listed. Angel investors, family offices, banks, accelerators and government vehicles are excluded because they are scored on a different basis and are not comparable.
How often is the ranking updated?
Scores are recomputed as new investments and portfolio outcomes are recorded, and this page refreshes daily.
My fund's data looks wrong. Can it be corrected?
Yes. Claim the fund's profile on Brouky to review the underlying investments and portfolio records, and the score updates from the corrected data.

Other rankings

GermanyUnited KingdomFranceNetherlandsSpainSwedenDenmarkItalyNorwayBelgiumFinlandCzech RepublicIrelandRomaniaPolandLuxembourgAustriaEstoniaPortugalUnited StatesIndiaIsraelSingaporeCanadaAustraliaChinaJapanUnited Arab Emirates